As of 2026-05-31, the EV/EBITDA ratio of Nichi-Iko Pharmaceutical Co Ltd (4541.T) is -1.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4541.T's latest enterprise value is 212,594.55 mil JPY. 4541.T's TTM EBITDA according to its financial statements is -142,247.00 mil JPY. Dividing these 2 quantities gives us the above 4541.T EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.3x - 6.5x | 5.8x |
| Forward P/E multiples | 5.4x - 6.5x | 5.9x |
| Fair Price | (1,362.26) - (1,572.42) | (1,449.15) |
| Upside | -3992.2% - -4592.6% | -4240.4% |
| Date | EV/EBITDA |